{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:50:20Z","timestamp":1793155820910,"version":"4.5.0"},"reference-count":47,"publisher":"Informa UK Limited","issue":"17","funder":[{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.2217\/imt-2023-0103","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:24:37Z","timestamp":1697441077000},"page":"1449-1457","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Secukinumab in the Treatment of Hidradenitis Suppurativa"],"prefix":"10.1080","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6917-5277","authenticated-orcid":false,"given":"Corey L","family":"Snyder","sequence":"first","affiliation":[{"name":"Clinical Laboratory for Epidemiology & Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA\ufffd\ufffd02215, USA"},{"name":"University of Texas Southwestern Medical School, Dallas, TX\ufffd\ufffd75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-7987","authenticated-orcid":false,"given":"Ruby S","family":"Gibson","sequence":"additional","affiliation":[{"name":"Clinical Laboratory for Epidemiology & Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA\ufffd\ufffd02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4738-4385","authenticated-orcid":false,"given":"Martina L","family":"Porter","sequence":"additional","affiliation":[{"name":"Clinical Laboratory for Epidemiology & Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA\ufffd\ufffd02215, USA"},{"name":"Harvard Medical School, Department of Dermatology, Boston, MA\ufffd\ufffd02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9405-0479","authenticated-orcid":false,"given":"Alexa B","family":"Kimball","sequence":"additional","affiliation":[{"name":"Clinical Laboratory for Epidemiology & Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, MA\ufffd\ufffd02215, USA"},{"name":"Harvard Medical School, Department of Dermatology, Boston, MA\ufffd\ufffd02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.090"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19435"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.0201"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.03.041"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.11.068"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18136709"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.08.056"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18473"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.07.045"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.05.033"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10254.x"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0749"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108402"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01682"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14619"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903907"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504370"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.02.068"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00022-3"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.02.068"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020455"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15691"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.10.010"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-00956-6"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0802107"},{"issue":"6","key":"e_1_3_5_28_1","first-page":"45","article-title":"Precertification, denials and appeals: reducing the hassles","volume":"13","author":"Akosa AN","year":"2006","unstructured":"Akosa AN . Precertification, denials and appeals: reducing the hassles. Fam. Pract. Manag.13(6), 45\u201348 (2006).","journal-title":"Fam. Pract. Manag."},{"key":"e_1_3_5_29_1","unstructured":"Two centuries of progress in one short timeline. National Psoriasis Foundation. www.psoriasis.org\/advance\/two-centuries-of-progress-in-one-short-timeline\/"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1743811"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108402"},{"key":"e_1_3_5_32_1","unstructured":"ClinicalTrials.gov\n. IL-17+inhibitor \u2013 list results. https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=il-17%2Binhibitor&cntry=&state=&city=&dist="},{"key":"e_1_3_5_33_1","unstructured":"ClinicalTrials.gov\n. Hidradenitis+suppurativa \u2013 list results. https:\/\/clinicaltrials.gov\/ct2\/results?cond=Hidradenitis%2BSuppurativa&term=&cntry=&state=&city=&dist="},{"key":"e_1_3_5_34_1","volume-title":"2023 American Academy of Dermatology (AAD) Annual Meeting.","author":"Kimball AB","year":"2023","unstructured":"Kimball AB , ZouboulisCC , SayedCet al. Bimekizumab in patients with moderate-to-severe hidradenitis suppurativa: 48-week efficacy and safety from BE HEARD I & II, two phase 3, randomized, double-blind, placebo-controlled, multicenter studies. Presented at: 2023 American Academy of Dermatology (AAD) Annual Meeting.LO, USA (March 2023)."},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.876"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.4805"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.05.022"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.2905"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.090"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.02.005"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17822"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S391356"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13216"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314258"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12751"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13348"},{"key":"e_1_3_5_47_1","unstructured":"Cosentyx [package insert]. Food and Drug Administration: Novartis Pharmaceuticals Corporation East Hanover NJ USA (2016). www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/125504s001s002lbl.pdf"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214273"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2019.08.001"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2023-0103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T16:20:11Z","timestamp":1715962811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2023-0103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":47,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.2217\/imt-2023-0103"],"URL":"https:\/\/doi.org\/10.2217\/imt-2023-0103","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}